Investment Summary

EQT Life Sciences Invests In HotSpot Therapeutics

On November 30, 2021, growth capital firm EQT Life Sciences invested in life science company HotSpot Therapeutics

Investment Highlights
  • This is EQT Life Sciences’ 27th transaction in the Life Science sector.
  • This is EQT Life Sciences’ 11th transaction in the United States.
  • This is EQT Life Sciences’ 3rd transaction in Massachusetts.

Investment Summary
Date 2021-11-30
Target HotSpot Therapeutics
Sector Life Science
Investor(s) EQT Life Sciences
Deal Type Venture

Target

HotSpot Therapeutics

Boston, Massachusetts, United States
HotSpot Therapeutics is a biotechnology company focused on discovering nature’s regulatory sites to advance allosteric drug discovery. HotSpot Therapeutics was formed in 2017 and is based in Boston, Massachusetts.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

EQT Life Sciences

Category Growth Capital Firm
Founded 1987
PE ASSETS 2.0B USD
Size Large
Type Sector Focused
DESCRIPTION

DEAL STATS #
Overall 43 of 47
Sector (Life Science) 27 of 30
Type (Venture) 37 of 39
State (Massachusetts) 3 of 3
Country (United States) 11 of 11
Year (2021) 11 of 12
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-10-22 Egle

Paris, France

Egle is a biotechnology company focused on developing first in class T-regulatory cell therapies based on Treg-starvers for oncology and autoimmune diseases. Egle was founded in 2020 and is based in Paris, France.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-12-08 AviadoBio

London, United Kingdom

AviadoBio is a pioneering gene therapy company focused on developing and delivering transformative medicines for people living with neurodegenerative disorders. AviadoBio was founded in 2019 and is based in London, United Kingdom,

Buy -
Mergr

Product

Company

Legal